ORION CHLORAL HYDRATE MIXTURE 1g/10mL bottle Australia - English - Department of Health (Therapeutic Goods Administration)

orion chloral hydrate mixture 1g/10ml bottle

orion laboratories pty ltd t/a perrigo australia - chloral hydrate, quantity: 100 mg/ml - oral liquid, solution - excipient ingredients: sucrose; citric acid; sodium citrate dihydrate; saccharin sodium; glycerol; methyl hydroxybenzoate; ethanol; propylene glycol; purified water; flavour - indications as at 19 september 2003: chloral hydrate mixture is indicated pre-operatively to produce sedation. it is also indicated for short term (not more than 2 weeks) use as a hypnotic to assist in sleep disorders.

DUKORAL oral inactivated cholera vaccine liquid vial and buffer powder sachet Australia - English - Department of Health (Therapeutic Goods Administration)

dukoral oral inactivated cholera vaccine liquid vial and buffer powder sachet

seqirus pty ltd - vibrio cholerae, quantity: 31.25 billion organisms; vibrio cholerae, quantity: 1 mg - oral liquid, suspension - excipient ingredients: sodium chloride; dibasic sodium phosphate dihydrate; water for injections; monobasic sodium phosphate dihydrate - cholera caused by serogroup 01 vibrio cholerae: active immunisation of adults and children from two years of age, who will be visiting areas epidemic or endemic for cholera and who are at high risk of infection.

Neoral New Zealand - English - Medsafe (Medicines Safety Authority)

neoral

novartis new zealand ltd - ciclosporin 100 mg/ml;   - oral solution - 100 mg/ml - active: ciclosporin 100 mg/ml   excipient: corn oil dl-alpha tocopherol ethanol polyethylene glycol hydrogenated castor oil propylene glycol - transplantation indications solid organ transplantation prevention of graft rejection following kidney, liver, heart, combined heart-lung, lung or pancreas allogeneic transplantations. treatment of transplant rejection in patients previously receiving other immunosuppressive agents. bone marrow transplantation prevention of graft rejection following bone marrow transplantation. prevention or treatment of graft-versus-host disease (gvhd).